1. A functional type II-A CRISPR–Cas system from Listeria enables efficient genome editing of large non-integrating bacteriophage. Issue 13 (22nd June 2018) Authors: Hupfeld, Mario; Trasanidou, Despoina; Ramazzini, Livia; Klumpp, Jochen; Loessner, Martin J; Kilcher, Samuel Journal: Nucleic acids research Issue: Volume 46:Issue 13(2018) Page Start: 6920 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A perfect fit: Bacteriophage receptor-binding proteins for diagnostic and therapeutic applications. (February 2023) Authors: Klumpp, Jochen; Dunne, Matthew; Loessner, Martin J Journal: Current opinion in microbiology Issue: Volume 71(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bacteriophage endolysins as novel antimicrobials. (October 2012) Authors: Schmelcher, Mathias; Donovan, David M; Loessner, Martin J Journal: Future microbiology Issue: Volume 7:Number 10(2012) Page Start: 1147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bacteriophage endolysins — extending their application to tissues and the bloodstream. (April 2021) Authors: Schmelcher, Mathias; Loessner, Martin J Journal: Current opinion in biotechnology Issue: Volume 68(2021) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bacteriophage endolysins: applications for food safety. (February 2016) Authors: Schmelcher, Mathias; Loessner, Martin J Journal: Current opinion in biotechnology Issue: Volume 37(2016) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bacteriophage endolysins: applications for food safety. (February 2016) Authors: Schmelcher, Mathias; Loessner, Martin J Journal: Current opinion in biotechnology Issue: Volume 37(2016) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Beyond antibacterials – exploring bacteriophages as antivirulence agents. (April 2021) Authors: Shen, Yang; Loessner, Martin J Journal: Current opinion in biotechnology Issue: Volume 68(2021) Page Start: 166 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Editorial overview: Phage therapy in the 21st century – inspired by biotechnology!. (April 2021) Authors: Lavigne, Rob; Loessner, Martin J Journal: Current opinion in biotechnology Issue: Volume 68(2021) Page Start: vi Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Editorial overview: Return of the phages — a new golden era of molecular discovery and synthetic biology. (April 2023) Authors: Harms, Alexander; Loessner, Martin J Journal: Current opinion in microbiology Issue: Volume 72(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Enhancing phage therapy through synthetic biology and genome engineering. (April 2021) Authors: Lenneman, Bryan R; Fernbach, Jonas; Loessner, Martin J; Lu, Timothy K; Kilcher, Samuel Journal: Current opinion in biotechnology Issue: Volume 68(2021) Page Start: 151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗